|
HS Code |
716297 |
| Productname | 4-Boc-1-Fmoc-2-Piperazinecarboxylic Acid |
| Casnumber | 1312391-94-6 |
| Molecularformula | C23H27N3O6 |
| Molecularweight | 441.48 |
| Appearance | White to off-white solid |
| Purity | Typically ≥95% |
| Solubility | Soluble in DMSO, DMF, and other polar organic solvents |
| Storagetemperature | 2-8°C (Refrigerated) |
| Protectinggroups | Boc (tert-butoxycarbonyl), Fmoc (9-fluorenylmethyloxycarbonyl) |
| Functionalgroups | Carboxylic acid, Piperazine, Boc, Fmoc |
| Usage | Peptide synthesis, pharmaceutical intermediate |
As an accredited 4-Boc-1-Fmoc-2-Piperazinecarboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, sealed HDPE bottle labeled "4-Boc-1-Fmoc-2-Piperazinecarboxylic Acid, 5 grams," with hazard, batch, and storage information. |
| Shipping | **Shipping Description:** 4-Boc-1-Fmoc-2-Piperazinecarboxylic Acid is shipped in tightly sealed containers under cool, dry conditions to ensure stability and prevent degradation. The chemical should be handled as per standard laboratory safety protocols. Shipping complies with relevant local and international regulations for non-hazardous, research chemical substances. |
| Storage | 4-Boc-1-Fmoc-2-Piperazinecarboxylic Acid should be stored in a tightly sealed container, away from moisture, light, and incompatible materials. Keep it at 2-8°C (refrigerator temperature) in a dry, well-ventilated area. Avoid exposure to direct sunlight and extreme temperatures. Ensure proper labeling, and handle under an inert atmosphere if recommended by the supplier for extended stability. |
Applications of 4-Boc-1-Fmoc-2-Piperazinecarboxylic Acid in Industrial Manufacturing4-Boc-1-Fmoc-2-Piperazinecarboxylic Acid serves as an advanced chemical intermediate primarily in high-value pharmaceutical and peptide synthesis. The material’s dual protection groups support selective reactions and structural control. We summarize below the principal industrial application sectors verified by downstream integration, each with its unique compliance, formula, processing, and end uses. 1. Peptide Drug Active Pharmaceutical Ingredient (API) SynthesisThis intermediate is key in the manufacturing of synthetic peptide APIs, where both Boc and Fmoc groups enable precise stepwise peptide elongation and orthogonal deprotection regimes. Industrial peptide lines incorporate this compound during solid-phase and solution-phase synthesis cycles, optimizing for yield, purity, and target sequence complexity, especially for small molecule peptide conjugates and complex cyclic peptides. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Pharmaceutical Research & Development (FTE and NCE Programs)Medicinal chemistry groups employ this protected piperazine during library design for new chemical entities, where controlled introduction prevents premature side reactions. Custom synthesis and FTE (Full-Time Equivalent) projects rely on its predictable deprotection profile for focused SAR studies, fragment linking, and candidate scale-up feasibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Custom Peptide Manufacturing for Diagnostic KitsClinical and industrial diagnostic kit producers require high-purity short peptides as critical assay reagents. This molecule’s dual protection allows for accurate sequential assembly and minimal racemization during the manufacture of customer-specified immunogenic or marker peptides. Custom manufacturing integrates this building block at the resin-to-reagent transition point for biotinylated, fluorescent, or antibody-binding peptide tags. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Peptidomimetic Compound ManufacturingChemists use this protected piperazine acid to build stable peptidomimetics where amide bonds resist enzymatic degradation, enhancing drug candidate profiles. The compound enters synthetic routes for beta-turn mimetics and backbone-modified analogs with applications in inflammation, oncology, and metabolic disease pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. CRO/CDMO Contract Synthesis ServicesContract research and manufacturing organizations integrate this intermediate into customer-driven synthesis projects, particularly for pilot scale and clinical supply. Its utilization centers on rapid-turnaround, multi-kilo batch runs for building protected peptide chains within tightly regulated process controls and documentation requirements, supporting both research and IND-stage clients. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Biotechnological Tool Compound ProductionLife sciences and biotechnology firms require protected piperazine derivatives for constructing chemical probes, cross-linkers, and bioconjugates. Specifically, this compound supports the synthesis of bifunctional molecules for chemical biology, protein engineering, and cell imaging, enabling spatial control over reactivity and site-specific attachment strategies within assay systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Boc-1-Fmoc-2-Piperazinecarboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
At our facility, 4-Boc-1-Fmoc-2-piperazinecarboxylic acid stands as a cornerstone among our custom building blocks. In the lab, we’ve run hundreds of controlled reactions on this molecule across different scales—sometimes by the gram, sometimes in multi-kilo batches—watching its role in peptide synthesis and beyond expand at a steady pace.
Chemists who order this compound often mention one thing: they want both purity and stability. Working with this compound every day, our staff see that clear envelopes, controlled environments, and fresh reagents make all the difference. The molecule brings a unique dual-protecting group format—Boc on one end and Fmoc on the other—which saves steps in solid-phase synthesis. Researchers appreciate that duality for preparing custom piperazine derivatives without masking or masking-protection manipulations mid-project.
We don’t just scale up by adjusting proportions; we analyze critical points in the process. Stirring means stirring, not letting it sit and “hope for the best.” The solvent grades affect yield as much as temperature control. Over the years, we’ve tightened every part of the workflow, from starting material purification to filtration and rotary evaporation, to deliver a compound that meets high HPLC purity—often beyond 98%.
Specs set on our in-house machines reflect what customers test for in their own QC labs. NMR, LC-MS, IR—every certificate reflects the hands-on calibration and monitoring carried out by our analytical team. Chemists expect reproducibility, so we offer batch samples at each stage, keeping the dialogue open about any suspected contaminants or batch deviations.
4-Boc-1-Fmoc-2-piperazinecarboxylic acid typically leaves our lab as a white to almost off-white powder. Physical appearance isn’t the only sign of quality, though. Flowability, especially in humid climates, affects automated dosing and weighing. Too dry, and the material generates static, clings to containers, and challenges transfer. Not dry enough, and it may form clumps.
Years spent troubleshooting led us to optimize drying and packaging methods. We use low-static containers and double-sealed bags, which has cut handling complaints and improved dosage uniformity for automated dispensers. Simple details like weighing protocols, glassware rinsing, and label visibility make a surprising difference in a chemist’s workflow, so we focus on those, too.
Many pharmaceutical and biotech R&D teams use this product when targeting N-protected intermediates. The dual protection gives flexibility to access both ends of the piperazine, which enables sequential deprotection steps or selective coupling to carboxylic acid and amine sites. That speeds up route scouting for both peptides and heterocyclic libraries.
Our batch records show a range of applications: from solid-phase peptide syntheses, where Fmoc protection streamlines the N-terminal unmasking, to solution-phase modifications, where Boc is removed under milder acid than standard amide groups. The ability to go either way—Fmoc off first or Boc off first—lets chemists avoid unwanted cross-reactions or wasted starting material.
Others use it as a core fragment for medicinal chemistry, connecting the backbone to linkers, fluorescent tags, or PEG chains. In these roles, the integrity of the product defines downstream yield. Customers have described how inferior grades from other sources ruined entire synthetic runs, pointing to the importance of consistent prep and unambiguous characterization.
Direct comparisons matter most to those who’ve tried working with unprotected or singly protected analogs. With only a Boc or Fmoc group in place, chemists encounter limits, especially if synthesis plans change mid-experiment. Lacking dual functionality, side reactions start piling up—cross-coupling difficulties, unplanned amine alkylation, or loss of entire batches due to unwanted deprotection under strong bases or acids.
Some researchers fixate on price or lead time, then end up sacrificing efficiency and predictability. We see it all the time. Our 4-Boc-1-Fmoc-2-piperazinecarboxylic acid gives more headroom on both ends of the molecule: no scrambling to re-protect, no mess from incomplete reactions. Working hands-on, we noticed fewer cleanup steps, less waste, and fewer headaches in isolating final targets.
Another overlooked point lies in reaction compatibility. Some alternate analogs interact with coupling agents differently. Residual solvents or less robust protection can react with HATU or DCC, generating side products that set off longer purification times. Our controlled drying and final QC check—backed up with real in-process records—give peace of mind for those running parallel syntheses or scaling up quickly.
Even with decades of collective staff knowledge, a few persistent hurdles always return. Humidity spikes, accidental exposure to direct sunlight, and poor bag seals can degrade sensitive protecting groups—especially Fmoc. Storage protocols at our site require temperature logs and batch checks on arrival, not just once a week or “as needed.” High staff turnover? Every new technician spends time shadowing the senior crew, picking up practical pointers that manuals never mention.
We face the realities of raw material price swings and fluctuating demand. Having a flexible inventory system, our operations team coordinates with regular clients to forecast needs. Even if a last-minute order lands, we try to keep enough material in validated storage so delivery is measured in days, not weeks. Downtime in our reactors is spent recalibrating or validating cleaning workflows, so there’s no slip-up on product-to-product cross-contamination.
Direct feedback pushes us to keep pushing HPLC and NMR checks tighter than market norm. Not long ago, we invested in new column setups that isolated trace byproducts—sometimes under 1%—that used to escape detection. That refinement closed gaps for customers running sensitive biological assays, where trace impurities can affect enzyme inhibition or pharmacokinetics studies.
Packaging isn’t just cosmetic either. We log every batch to trace back not only to its immediate run, but also to the preceding synthesis. Each lot documents solvents, batch numbers on all inputs, reaction temperatures, and drying curves. If something goes astray for a customer, we routinely review all process data, spot outliers, and offer guidance on trouble-shooting, supporting both small startups and global R&D leaders.
Chemical manufacturing often attracts scrutiny over waste, solvents, or energy use. In our plant, solvent recovery platforms recapture a good proportion of acetonitrile and dichloromethane used in purification. Not every batch is recoverable to 100%, but with regular runs, solvent loads and waste drum volumes have fallen over the last five years. Strict chemical hygiene and waste logs ensure sensitive components, like Fmoc derivatives, don’t mix into routine plant washouts.
In scale-up, minor changes reveal big downstream impacts. Switching a filtration paper grade or altering the grind size of starting material can affect both yield and final appearance. Teams document each change, re-check stability, and communicate openly with customers. The feedback loop with experienced chemists around the world keeps the process alive, not static. Practical innovation comes in the form of equipment upgrades, incremental yield gains, and safer workflows—not just R&D slogans.
Beyond the basic order sheet, many customers write to ask which solvents dissolve the powder efficiently or whether basic neutralization might affect piperazine rings. We answer with details from our own lab: solvents like DMF, DCM, or NMP tackle the bulk efficiently, but high-purity THF sometimes boosts solubility for rapid processing. For those using automated peptide synthesizers, we share tips on feed rates and dilution limits, all based on actual lab experience rather than broad generalizations.
On rare occasions, we’ve supported clients struggling with high background during cleavage or needing alternate sequences of deprotection. Our team draws from hundreds of test runs. We’ve seen variable Fmoc/Boc reactivity on different resins or solid supports and are happy to advise from the ground up—a practice that saves both material and time.
Over the last several years, demand for robust, multifunctional protecting groups has shifted with the rise of oligonucleotide-peptide conjugates and bifunctional linker technologies. The versatility of 4-Boc-1-Fmoc-2-piperazinecarboxylic acid pushes it to the front of these projects. With more global groups challenging traditional peptide formats, the importance of reliable, clean intermediates gets even greater.
Some clients ask for new documentation in light of evolving regulatory standards—from residual solvent reporting to elemental analysis certificates. Growing export controls focus more attention on chain of custody and environmentally sound disposal procedures. Working directly with auditors and regulatory liaisons, we rework production logs, offer voluntary disclosures, and answer specific questions so clients feel confident about their supply chain.
Decision-makers look at long-term data. Our records—both on paper and digital—track every lot’s journey from order to synthesis to shipping. Recurring patterns reveal best practices: seasonal adjustments in storage, minor tweaks in purification, and discipline with temperature cycles. Known best by those who actually work hands-on with specialty intermediates, small details eventually add up to a dependable supply line.
Subtle flaws like trace trace levels of DCM or off-spec carbon peaks in NMR can make expensive failures for those further down the supply chain. Large compound libraries and high-value diagnostics depend heavily on the integrity of their starting blocks. Returning customers appreciate candid communication—we don’t sugarcoat bad news or overpromise on batch specs. Open records and feedback loops keep output not only reliable but also customizable to evolving chemistry challenges.
Interest in more elaborate conjugate and hybrid project workflows grows every year. Multistep buildouts often run more smoothly when both Boc and Fmoc protections are present during early stages. Adaptability means fewer workarounds, fewer wasted cycles, and less need for post-synthesis patch-ups. As more end-users explore modifications to piperazine-based systems in imaging, drug delivery, and polymer sciences, these features gain new significance.
Ongoing dialogue with the bench chemist remains at the core. Only by listening to everyday processing frustrations can we adapt both compound and process. Whether adjusting packaging for automated dispensing systems or offering custom labeling, front-line staff understand how even small manufacturing changes play out on the bench.
Producing 4-Boc-1-Fmoc-2-piperazinecarboxylic acid in-house, rather than through third-party packaging or brokers, delivers two things: fast responsiveness and consistent quality control. Learnt from hands-on experience, unexpected setbacks—such as resin incompatibility or storage temperature excursions—are easier to troubleshoot with documentation from the actual production line rather than distantly sourced generic specs.
Customers sometimes share stories where buying through intermediaries led to delayed shipments, or ambiguous answers regarding stability. Direct feedback informs every adjustment in our facility. Our control over the full lifecycle—from raw material sourcing through to shipping—lets us make changes in real time. No need to filter through layers of resellers for answers or improvements.
Every lot mirrors the best practices of those who work directly with the molecule. The people on the floor—measuring, mixing, running controls—are chemists, not just operators. This practical background influences everything from solvent choices to communication with customers. Long-term relationships develop through transparency and a shared drive to deliver not just product, but true process support.
Chemicals like 4-Boc-1-Fmoc-2-piperazinecarboxylic acid play outsized roles in both research speed and result reliability. Our role as direct manufacturer lets us keep these advantages as close as possible to the people who depend on them every day.